Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP492944.RAdpgmmLt_r4WtuId99VoAvQCYCe4XF8esdgxgIQW4q00130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP492944.RAdpgmmLt_r4WtuId99VoAvQCYCe4XF8esdgxgIQW4q00130_assertion type Assertion NP492944.RAdpgmmLt_r4WtuId99VoAvQCYCe4XF8esdgxgIQW4q00130_head.
- NP492944.RAdpgmmLt_r4WtuId99VoAvQCYCe4XF8esdgxgIQW4q00130_assertion description "[One agent, containing human interleukin-2 and truncated diphtheria toxin (denileukin diftitox), has been approved for use in cutaneous T-cell lymphoma, and has shown activity in other hematologic malignancies, including leukemias and lymphomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP492944.RAdpgmmLt_r4WtuId99VoAvQCYCe4XF8esdgxgIQW4q00130_provenance.
- NP492944.RAdpgmmLt_r4WtuId99VoAvQCYCe4XF8esdgxgIQW4q00130_assertion evidence source_evidence_literature NP492944.RAdpgmmLt_r4WtuId99VoAvQCYCe4XF8esdgxgIQW4q00130_provenance.
- NP492944.RAdpgmmLt_r4WtuId99VoAvQCYCe4XF8esdgxgIQW4q00130_assertion SIO_000772 19344187 NP492944.RAdpgmmLt_r4WtuId99VoAvQCYCe4XF8esdgxgIQW4q00130_provenance.
- NP492944.RAdpgmmLt_r4WtuId99VoAvQCYCe4XF8esdgxgIQW4q00130_assertion wasDerivedFrom befree-20150227 NP492944.RAdpgmmLt_r4WtuId99VoAvQCYCe4XF8esdgxgIQW4q00130_provenance.
- NP492944.RAdpgmmLt_r4WtuId99VoAvQCYCe4XF8esdgxgIQW4q00130_assertion wasGeneratedBy ECO_0000203 NP492944.RAdpgmmLt_r4WtuId99VoAvQCYCe4XF8esdgxgIQW4q00130_provenance.